| Forward-Looking Statements
This presentation includes forward‐looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All
statements other than statements of historical facts contained in these materials or elsewhere, including statements regarding
Harmony Biosciences Holdings, Inc.’s (the “Company”) future financial position, business strategy and plans and objectives of
management for future operations, should be considered forward-looking statements. Forward-looking statements use words like
“believes,” “plans,” “expects,” “intends,” “will,” “would,” “anticipates,” “estimates,” “may,” “could,” “might,” “continue,” “potential,” and
similar words or expressions in discussions of the Company’s future operations, financial performance or the Company’s strategies,
but the absence of these words does not mean that a statement is not forward-looking. These statements are based on current
expectations or objectives that are inherently uncertain. These forward-looking statements involve significant risks and uncertainties
that could cause the actual results to differ materially from the expressed or implied forwarding-looking statements, including, but not
limited to the risk factors discussed under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K filed with the U.S.
Securities and Exchange Commission (the “SEC”) on February 22, 2024 and its other filings with the SEC. While the Company may
elect to update such forward-looking statements at some point in the future, it disclaims any obligation to do so, even if subsequent
events cause its views to change.
This presentation includes information related to market opportunity as well as cost and other estimates obtained from internal
analyses and external sources. The internal analyses are based upon management’s understanding of market and industry conditions
and have not been verified by independent sources. Similarly, the externally sourced information has been obtained from sources the
Company believes to be reliable, but the accuracy and completeness of such information cannot be assured. Neither the Company,
nor any of its respective officers, directors, managers, employees, agents, or representatives, (i) make any representations or
warranties, express or implied, with respect to any of the information contained herein, including the accuracy or completeness of this
presentation or any other written or oral information made available to any interested party or its advisor (and any liability therefore is
expressly disclaimed), (ii) have any liability from the use of the information, including with respect to any forward-looking statements, or
(iii) undertake to update any of the information contained herein or provide additional information as a result of new information or
future events or developments.
2 October 1, 2024 Harmony Biosciences | Investor Day |